Passage Bio Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$4.21

+0.13 (+3.19%)

As of May 16, 2:24 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +762.9% upside

Low Target $21.56

Average Target $36.33

High Target $42.60

Current Price $4.21

Current
$4.21

Target
$36.33

$21.56 $36.33 avg $42.60

Scenario Analysis

Bear Case

$21.56

412.1%

Low target

Base Case

$36.33

+762.9%

Avg target

Bull Case

$42.60

+911.9%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$20.00

-79.0% from high

52-Week Low

$3.94

+7.0% from low

Target vs 52W High

$36.33

+81.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%